共识推荐:EGFR敏感突变的晚期NSCLC老年患者,一线推荐EGFR-TKIs治疗,与总体人群具有相似的生存获益,即使高龄患者也可以从EGFR-TKIs中获益。. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.